Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer

[1]  Kazuhiro Yoshida,et al.  Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis , 2022, Journal of hepato-biliary-pancreatic sciences.

[2]  K. Takami,et al.  Outcomes of surgical resection for pulmonary metastasis from ovarian cancer , 2020, Journal of Cardiothoracic Surgery.

[3]  K. Takami,et al.  Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era , 2020, Annals of Surgical Oncology.

[4]  S. Natsugoe,et al.  Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[5]  P. Bhosale,et al.  Imaging findings of recurrent pancreatic cancer following resection , 2018, Abdominal Radiology.

[6]  T. Ohtsuka,et al.  Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence , 2017, World Journal of Surgery.

[7]  B. Melichar,et al.  Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature , 2017, World journal of gastroenterology.

[8]  H. Groen,et al.  Long‐term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  M. Mori,et al.  Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy , 2017, Surgery Today.

[10]  J. Werner,et al.  Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[11]  J. Fontaine,et al.  Pulmonary metastasectomy for suspected pancreaticobiliary cancer. , 2016, The Journal of thoracic and cardiovascular surgery.

[12]  M. Higashiyama,et al.  Pulmonary metastasectomy: outcomes and issues according to the type of surgical resection , 2015, General Thoracic and Cardiovascular Surgery.

[13]  A. Hinke,et al.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. , 2013, JAMA.

[14]  J. Cameron,et al.  Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival , 2011, Journal of Gastrointestinal Surgery.

[15]  H. Ueno,et al.  A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer , 2009, British Journal of Cancer.

[16]  B. Topal,et al.  Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  Peter Neuhaus,et al.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.

[18]  K. Doi,et al.  Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. , 2004, Radiology.

[19]  N. Asaoka,et al.  Computed tomography of lung cancer: frequency and characteristics of calcification. , 2003, Internal medicine.

[20]  Kenji Suzuki,et al.  Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. , 2001, The Journal of thoracic and cardiovascular surgery.

[21]  J. Austin,et al.  CT Demonstration of Calcification in Carcinoma of the Lung , 1994, Journal of computer assisted tomography.

[22]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[23]  P. Illei,et al.  Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. , 2010, Human pathology.